Summary of the most important variables to predict GVHD and NRM in univariate analysis
Variable . | Polymorphism . | D/R . | OR* . | ||||
---|---|---|---|---|---|---|---|
aGVHD 2-4 . | aGVHD 3-4 . | cGVHD . | Extensive cGVHD . | NRM . | |||
Clinical | |||||||
Recipient age >45 y | H | H | |||||
Recipient sex, male vs female | H | ||||||
Female donor/male recipient | H | ||||||
MDS | H | ||||||
Conditioning, RIC vs MAC | H | H | |||||
Conditioning regimen, no TBI vs TBI | H | ||||||
Stem-cell source, PB vs BM | H | H | |||||
aGVHD, grade 2-4 | H | H | |||||
Genetic | |||||||
IL-1A | rs1800587 | D | H | ||||
IL-1B | rs1143627 | R | H | ||||
D | L | ||||||
rs16944 | R | H | |||||
D | H | ||||||
rs1143634 | R | H | |||||
D | H | ||||||
IL-2 | rs2069762 | R | H | ||||
IL-6 | rs1800795 | R | H | ||||
IL-17A | rs8193036 | D | H | ||||
rs4711998 | R | H | H | ||||
D | H | ||||||
rs2275913 | R | H | |||||
rs3819024 | D | L | |||||
R | L | ||||||
IL-23R | rs6687620 | R | H | H | |||
D | H | ||||||
rs11209026 | R | H | |||||
TGFβ | rs1800469 | D | H | ||||
INF-γ | rs2069705 | R | H |
Variable . | Polymorphism . | D/R . | OR* . | ||||
---|---|---|---|---|---|---|---|
aGVHD 2-4 . | aGVHD 3-4 . | cGVHD . | Extensive cGVHD . | NRM . | |||
Clinical | |||||||
Recipient age >45 y | H | H | |||||
Recipient sex, male vs female | H | ||||||
Female donor/male recipient | H | ||||||
MDS | H | ||||||
Conditioning, RIC vs MAC | H | H | |||||
Conditioning regimen, no TBI vs TBI | H | ||||||
Stem-cell source, PB vs BM | H | H | |||||
aGVHD, grade 2-4 | H | H | |||||
Genetic | |||||||
IL-1A | rs1800587 | D | H | ||||
IL-1B | rs1143627 | R | H | ||||
D | L | ||||||
rs16944 | R | H | |||||
D | H | ||||||
rs1143634 | R | H | |||||
D | H | ||||||
IL-2 | rs2069762 | R | H | ||||
IL-6 | rs1800795 | R | H | ||||
IL-17A | rs8193036 | D | H | ||||
rs4711998 | R | H | H | ||||
D | H | ||||||
rs2275913 | R | H | |||||
rs3819024 | D | L | |||||
R | L | ||||||
IL-23R | rs6687620 | R | H | H | |||
D | H | ||||||
rs11209026 | R | H | |||||
TGFβ | rs1800469 | D | H | ||||
INF-γ | rs2069705 | R | H |
All variables are statistically significant (P < .05).
BM, bone marrow; D, donor; H, higher risk; L, lower risk; MAC, myeloablative conditioning; OR, odds ratio; PB, peripheral blood; R, recipient; RIC, reduced-intensity conditioning.
OR = 1 (neutral); OR < 1 (L); OR > 1 (H).